Detalhe da pesquisa
1.
Synthesis and Characterization of Hypervalent Pentacoordinate Carbon Compounds Bearing a 7-6-7-Ring Skeleton.
Chemistry
; 29(9): e202203162, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372771
2.
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.
Endocr J
; 67(11): 1127-1138, 2020 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32612066
3.
Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
Endocr J
; 66(4): 329-336, 2019 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760658
4.
Pheochromocytoma With High Adrenocorticotropic Hormone Production Capacity Without Pigmentation and Cushingoid Symptoms: A Case Report With a Literature Review.
Cureus
; 16(2): e53358, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38435205
5.
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD.
J Diabetes Investig
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775319
6.
Anagliptin Monotherapy for Six Months in Patients With Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single-Arm Intervention Trial.
J Clin Med Res
; 13(10-11): 502-509, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34925661
7.
Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial.
Diabetes Ther
; 12(12): 3201-3215, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709582
8.
Examination of Malignant Findings of Thyroid Nodules Using Thyroid Ultrasonography.
J Clin Med Res
; 12(8): 499-507, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849938
9.
A Sudden Onset of Severe Thrombocytopenia While Using Evolocumab.
Case Rep Hematol
; 2020: 3281626, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274224
10.
Intrinsic insulin secretion capacity might be preserved by discontinuing anti-programmed cell death protein 1 antibody treatment in 'anti-programmed cell death protein 1 antibody-induced' fulminant type 1 diabetes.
J Diabetes Investig
; 9(2): 448-449, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29504279
11.
Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial.
Diabetes Care
; 40(10): 1364-1372, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751548
12.
Detailed Time Course of Decline in Serum C-Peptide Levels in Anti-Programmed Cell Death-1 Therapy-Induced Fulminant Type 1 Diabetes.
Diabetes Care
; 42(3): e40-e41, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659072